2-{2-[3-(3-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[3-(3-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[3-(3-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
Compound ID: | C202-1650 |
Compound Name: | 2-{2-[3-(3-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
Molecular Weight: | 551.44 |
Molecular Formula: | C26 H20 Br F N4 O2 S |
Smiles: | C1C(c2ccc(cc2)F)N(C2=NC(C(CC(Nc3ccccc3)=O)S2)=O)N=C1c1cccc(c1)[Br] |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 5.6701 |
logD: | 5.6701 |
logSw: | -5.8791 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 58.972 |
InChI Key: | YVYRRNWMJXMDSZ-UHFFFAOYSA-N |